Chargement en cours...
Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model
Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, and...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2018-11-01
|
| Collection: | Brazilian Journal of Infectious Diseases |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S1413867018304975 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|